Officer sold
~$630KReported value · 5,211 sh @ $120.93
Stock since the trade +0.6% · S&P 500 +1.0% · to Oct 5
Encompass Health's Chief Accounting Officer sold $630K of Encompass Health shares. Nobody planned it ahead of time.
Loading…
EHC · NYSE · Health Care Facilities
Health Care Facilities company based in Birmingham, Alabama.
In the last 90 days, no insider of Encompass Health reported an open-market purchase and 6 open-market sales worth about $26.4M. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$120.97
Last 12 months
Not enough history
Market value
$11.9B
Revenue
$1.6B
+9.6% vs the same quarter a year earlier
Free cash flow, last 12 months
$413M
This quarter $62.3M, a year earlier $113M
Net debt
$2.49B
Debt $2.6B, cash $108M, at Jun 30, 2026
Net income, last 12 months
$621M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 5, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
6 sales
$26.4M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$5.94B
+10.5% vs the year before
Net income, fiscal 2025
$566M
As reported in the annual filing
Shares outstanding
98.7M
As of Jul 28, 2026
In fiscal 2025 the company spent $158M buying back its own shares and $71.1M on dividends. Cash actually paid, from its cash-flow statement.
Stock since the trade +0.6% · S&P 500 +1.0% · to Oct 5
Encompass Health's Chief Accounting Officer sold $630K of Encompass Health shares. Nobody planned it ahead of time.
Stock since the trade +0.6% · S&P 500 +1.0% · to Oct 5
Encompass Health's Gen Counsel & Secretary sold $588K of Encompass Health shares. Nobody planned it ahead of time.
Stock since the trade −3.9% · S&P 500 +0.2% · to Oct 5
The boss of Encompass Health sold $21.5M of Encompass Health shares. Nobody planned it ahead of time.
Stock since the trade −3.9% · S&P 500 +0.2% · to Oct 5
The money chief of Encompass Health sold $2.37M of Encompass Health shares. Nobody planned it ahead of time.
Stock since the trade −3.9% · S&P 500 +0.2% · to Oct 5
Encompass Health's Gen Counsel & Secretary sold $1.12M of Encompass Health shares. Nobody planned it ahead of time.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $123.62 on Oct 6, 2025 to $120.97 on Oct 5, 2026 (-2.1%). Disclosed activity in the last 12 months: 0 insider purchases, 18 insider sales, 0 Congress purchases, 0 Congress sales.